Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Parabilis Medicines Inc | 5,266,697 | 5,266,697 | 0 | $144.15M | $170.06M | 34.29% | +$25.91M |
| Pharvaris N V COM | 4,643,430 | 4,458,977 | -184,453 | $160.57M | $141.44M | 28.52% | -$19.13M |
| Attovia Therapeutics Inc | 0 | 4,181,366 | +4,181,366 | $0 | $71.67M | 14.45% | +$71.67M |
| Achieve Life Science Inc | 5,914,720 | 5,914,720 | 0 | $38.62M | $47.85M | 9.65% | +$9.23M |
| Alumis Inc | 4,528,408 | 4,191,408 | -337,000 | $127.43M | $30.97M | 6.25% | -$96.45M |
| ALX Oncology Holdings Inc.(ALXO) | 12,884,638 | 12,884,638 | 0 | $26.67M | $17.91M | 3.61% | -$8.76M |
| Yarrow Bioscience Inc | 0 | 554,769 | +554,769 | $0 | $12.49M | 2.52% | +$12.49M |
| Lyell Immunopharma, Inc.(LYEL) | 337,697 | 337,697 | 0 | $4.74M | $3.31M | 0.67% | -$1.44M |
| Lisata Therapeutics, Inc.(LSTA) | 0 | 156,460 | +156,460 | $0 | $225.3K | 0.05% | +$225.3K |
| Harmony Biosciences Holdings, Inc.(HRMY) | 472,194 | 0 | -472,194 | $17.19M | $0 | — | -$17.19M |